↓ Skip to main content

Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax

Overview of attention for article published in Leukemia Research Reports, August 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
9 Mendeley